Quidel reported $1.45B in Current Assets for its fiscal quarter ending in September of 2026.





Current Assets Change Date
Abbott USD 23.5B 1.02B Sep/2026
Agilent USD 4.69B 70M Jun/2026
Becton, Dickinson and Co. USD 8.32B 178M Sep/2026
Bruker USD 2.16B 67.9M Sep/2026
Cerus USD 174.38M 7.26M Dec/2025
Charles River Laboratories USD 1.54B 5.92M Sep/2026
Danaher USD 14.79B 1.41B Sep/2026
Haemonetics USD 855.53M 44.7M Sep/2026
Illumina USD 3.04B 201M Sep/2026
IQVIA Holdings USD 6.45B 225M Sep/2026
Merit Medical Systems USD 1.2B 86.58M Sep/2026
Mettler Toledo International USD 1.38B 28.79M Sep/2026
Myriad Genetics USD 289M 23.8M Jun/2026
Neogen USD 582.5M 22.1M Jun/2026
OraSure Technologies USD 222.94M 17.84M Jun/2026
Pacific Biosciences Of California USD 307.85M 30.78M Sep/2026
Quidel USD 1.45B 69.4M Sep/2026
Revvity USD 1.86B 436.33M Sep/2026
STAAR Surgical USD 353.43M 11.08M Sep/2026
Thermo Fisher Scientific USD 25.62B 2.25B Sep/2026
Waters USD 3.9B 186M Jun/2026